Comparison

AntiCoagAF vs Stroke Prevention in AFib

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

AntiCoagAF

Features
Read full description

This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF). It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban. Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information. Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.

About

Stroke Prevention in AFib

Features
Read full description

@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Ask Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Stroke Prevention in Atrial Fibrillation/Venous Thromboembolism content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

Screenshots

AntiCoagAF4 screens
Stroke Prevention in AFib4 screens

Verdict

The call

The clearest difference is price: Stroke Prevention in AFib at Free against AntiCoagAF's $1.99. Stroke Prevention in AFib also leads on update cadence (every 2 months vs every 13 months) and iOS requirement (14.0 vs 16.6). On ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ad data · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ad data · Monetization

Stroke Prevention in AFib is free to download; AntiCoagAF costs $1.99 up front. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

AntiCoagAF ships an update every 13 months, Stroke Prevention in AFib every 2 months. The most recent releases landed on November 19, 2026 and November 21, 2026 respectively.

Scorecard3 real differences · 3 level
AntiCoagAF versus Stroke Prevention in AFib: the parameters behind the verdict, then further details
ParameterAntiCoagAFStroke Prevention in AFib
Price$1.99Free — better
Update frequencyEvery 13 monthsEvery 2 months — better
Ad dataNoNo
In-app purchasesNoNo
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS16.614.0 — better
Further details — not scored
Size5 MB21 MB
Age rating17+12+
DeveloperCereScape Pty Ltd@Point of Care

In-app purchases

None

AntiCoagAF

No in-app purchases

None

Stroke Prevention in AFib

No in-app purchases

Questions

Is AntiCoagAF free?
AntiCoagAF costs $1.99, with no in-app purchases.
Is Stroke Prevention in AFib free?
Stroke Prevention in AFib is free to download, with no in-app purchases.
Do AntiCoagAF or Stroke Prevention in AFib have ads?
Neither AntiCoagAF nor Stroke Prevention in AFib lists data used for advertising in its App Store privacy details.
Which is updated more often, AntiCoagAF or Stroke Prevention in AFib?
AntiCoagAF ships an update every 13 months, and Stroke Prevention in AFib every 2 months. Most recently, AntiCoagAF was updated on November 19, 2026 and Stroke Prevention in AFib on November 21, 2026.

Other comparisons